What is the diagnosis and treatment for a child with a continuous machinery murmur heard best at the second left intercostal space?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Patent Ductus Arteriosus: Diagnosis and Management

A child with a continuous machinery murmur heard best at the second left intercostal space that is widely transmitted over the precordium most likely has a patent ductus arteriosus (PDA), which requires echocardiographic confirmation and may need closure depending on hemodynamic significance.

Diagnostic Approach

  • The classic "machinery" or "continuous" murmur heard best at the second left intercostal space is the hallmark physical finding of patent ductus arteriosus 1, 2
  • This characteristic murmur occurs due to continuous blood flow from the aorta to the pulmonary artery throughout both systole and diastole 2
  • Wide transmission across the precordium suggests significant left-to-right shunting through the PDA 1, 2
  • Echocardiography is indicated as a Class I recommendation for any child with a loud or abnormal murmur to confirm the diagnosis 1

Diagnostic Confirmation

  • Two-dimensional echocardiography with Doppler assessment is essential for:
    • Confirming PDA diagnosis 1, 3
    • Determining the size and shape of the ductus 3
    • Assessing hemodynamic significance (direction and magnitude of shunt) 1, 2
    • Evaluating for associated cardiac anomalies 1
    • Measuring left atrial and ventricular dimensions to assess volume overload 4

Management Approach

  • Management decisions depend on patient age, PDA size, and hemodynamic impact 2, 3:

For Hemodynamically Significant PDA:

  • Transcatheter closure is the preferred first-line treatment for most children beyond the neonatal period 3

    • Less invasive than surgery
    • Shorter hospital stay
    • Excellent safety profile
  • Surgical ligation may be considered when:

    • Transcatheter closure is technically not feasible 3
    • PDA anatomy is unfavorable for device closure 3
    • There is significant pulmonary hypertension requiring careful assessment 5

Special Considerations:

  • In patients with pulmonary arterial hypertension and PDA:

    • Consider PDA closure if pulmonary artery pressure is >2/3 of systemic pressure with net left-to-right shunt (Qp:Qs >1.5) 5
    • Avoid PDA closure in patients with Eisenmenger physiology (right-to-left shunting) 5
  • For preterm infants with PDA:

    • Medical management with prostaglandin inhibitors (indomethacin or ibuprofen lysine) may be attempted first 2, 6
    • Surgical intervention may be necessary if medical management fails 7

Complications and Follow-up

  • Untreated, hemodynamically significant PDA can lead to:

    • Left heart volume overload 4
    • Congestive heart failure 2
    • Pulmonary hypertension 3
    • Rare complications like AV block have been reported 4
  • Regular follow-up with a cardiologist is recommended after PDA closure to monitor for:

    • Resolution of left heart volume overload 4
    • Improvement in cardiac function 3
    • Development of any late complications 5

Pitfalls to Avoid

  • Don't mistake PDA for other causes of continuous murmurs such as:

    • Aortopulmonary window
    • Coronary arteriovenous fistula
    • Ruptured sinus of Valsalva aneurysm 1, 3
  • Avoid delaying diagnosis and treatment in symptomatic patients, as prolonged volume overload can lead to irreversible pulmonary hypertension 5, 3

  • Don't close a PDA in patients with ductal-dependent congenital heart lesions where the PDA is providing essential pulmonary or systemic blood flow 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Patent ductus arteriosus: an overview.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2007

Guideline

Management of Reverse Differential Cyanosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.